Acceleron Pharma OverviewAcceleron Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for XLRN.
Quarterly EBIT
-$70.63M
↓ 80.05% YoY
As of Sep 30, 2021
Annual EBIT (TTM)
-$255.49M
↓ 88.84% YoY
Trailing 12 months ending Sep 30, 2021
Acceleron Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for XLRN.
As of Sep 30, 2021
Trailing 12 months ending Sep 30, 2021